A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial
Antoinette de Waha*, Sigrid Sandner, Moritz von Scheidt, Andreas Boening, Katharina Koch-Buettner, Dieter Hammel, Rainer Hambrecht, Bernhard C. Danner, Friedrich A. Schöndube, Gerold Goerlach, Theodor Fischlein, Michael Schmoeckel, Martin Oberhoffer, Rainer Schulz, Thomas Walther, Tibor Ziegelhöffer, Christoph Knosalla, Felix Schönrath, Friedhelm Beyersdorf, Matthias SiepeTim Attmann, Martin Misfeld, Friedrich Wilhelm Mohr, Hans Hinrich Sievers, Alexander Joost, Leon M. Putman, Günther Laufer, Christian Hamm, Uwe Zeymer, Adnan Kastrati, Peter W. Radke, Rüdiger Lange, Jochen Cremer, Heribert Schunkert
Dive into the research topics of 'A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial'. Together they form a unique fingerprint.